Evidence map›Paper›PMID 27474031›Full record

ReviewDermatology and therapy2016

The Patient's Guide to Psoriasis Treatment. Part 3: Biologic Injectables.

Michael Abrouk, Mio Nakamura, Tian Hao Zhu, Benjamin Farahnik, Rasnik K Singh, Kristina M Lee, Margareth V Jose, John Koo, Tina Bhutani, Wilson Liao

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Dermatology and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Michael AbroukSchool of Medicine, University of California-Irvine, Irvine, CA, USA. michaelabrouk1@gmail.com.
Mio NakamuraDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California-San Francisco, San Francisco, CA, USA.
Tian Hao ZhuUniversity of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Benjamin FarahnikUniversity of Vermont College of Medicine, Burlington, VT, USA.
Rasnik K SinghDavid Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, CA, USA.
Kristina M LeeDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California-San Francisco, San Francisco, CA, USA.
Margareth V JoseDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California-San Francisco, San Francisco, CA, USA.
John KooDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California-San Francisco, San Francisco, CA, USA.
Tina BhutaniDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California-San Francisco, San Francisco, CA, USA.
Wilson LiaoDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California-San Francisco, San Francisco, CA, USA.
University of California, San Francisco · USUniversity of California, Irvine · USUniversity of California, Los Angeles · USUniversity of Southern California · USUniversity of Vermont · US

Funding

MHC and KIR Region Genomics in PsoriasisU01AI119125 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIAO, WILSON · 2015 to 2019
$3.5M
Identification of Causal Variants in PsoriasisR01AR065174 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIAO, WILSON · 2013 to 2016
$1.8M
NIAID NIH HHS U01 AI119125NIAMS NIH HHS R01 AR065174
6 · The paper itself

Abstract

backgroundAn increasing number of injectable biologics are now available for the treatment of psoriasis. However, for individuals who have never received this therapy, the process of performing a self-injection can be daunting. There is lack of patient educational material on how to perform and optimize this treatment.

objectiveThe objective of this study is to present a freely available online guide and video on biologic injections that is informative to patients and increases the success and compliance of patients starting this therapy.

methodsThe self-injection technique taught at the University of California-San Francisco Psoriasis and Skin Treatment Center as well as available information from the literature were reviewed to design a practical guide for patients receiving biologic injections.

resultsWe created a printable guide and video resource that describes how to improve the injection process, pain management, travel planning, and common concerns with biologic injectables.

conclusionThis guide is beneficial for patients who wish to improve their experience with biologic self-injections, for healthcare providers who prescribe these treatments, and for trainees learning about this modality.

Indexed as

AdalimumabBiologic agentsBiologicsEtanerceptIxekizumabPatient educationPsoriasisSecukinumabUstekinumabVideo guide

Identifiers

PMID27474031
PMCPMC4972737
OpenAlexW2477125582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.